Champions Oncology, Inc.
CSBRBiotechnology
$4.81−2.24%As of Oct 29vs prior close
- Market cap
- $66.9M
- P/E (TTM)
- –
- P/E (FY1)
- 48.1×
- From 52W high
- −38.33%
- EPS (LTM)
- -$0.08
- Revenue (LTM)
- $60.7M
- Net margin
- -1.87%
- Dividend yield
- 0.00%
Nomior Score
40
Steady ProfileSpeculativeBottom 28% of the scored universe
Growth50
Quality58
Value54
Momentum7
Resilience55
Growth
+14.41%revenue a year over 8 fiscal years
YE18 $20.2MLTM $60.7M
Connections
Revenue to profitQ1 YE27
The operating loss was 3% of revenue, narrower by 1 pt on a year.
Who owns it
1fund